| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | 0.14 | 0.01 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.01 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | 0.093 | 0.01 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.01 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |